Moderate Depression
14
2
3
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.1%
1 terminated out of 14 trials
83.3%
-3.2% vs benchmark
14%
2 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (14)
Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique
Abbreviated MBCT for Depression in Older Black or African American Breast Cancer Survivors
Nebulized Ketamine for the Treatment of Major Depressive Disorder
A Randomized Clinical Trial Comparing Active Versus Sham T-PEMF Headband Treatment for Depression
Treating Depression With Text Messaging
Feasibility Study of an Online Physical Activity Intervention for Youth With Depression
pBFS Guided 20min Inter-session Interval rTMS Treatment for MDD
The Dosage Effect of pBFS Guided rTMS Treatment for MDD
Effect of SSRIs on Response to Psilocybin Therapy
The Impact of Spiritual Healing on Moderate Depression in Adults
Effects and Consequences for Mother and Child From Treatment for Depression
Reducing Depressive Symptomatology With a Smartphone App
Task Sharing Counseling Intervention by Community Health Workers for Prenatal Depression in South Africa
Homeopathic Treatment for Depression in Peri- and Postmenopausal Women